Jarir Logo

Rhino-Sinusitis is a frequent problem in COPD:A case-control study

Printed Book
SR 293
Inclusive of VAT
Sold as: EACH
SR17Per Month/24 months
Author:Gerhards, Claudia
Date of Publication: 2015
Book classification:Medical Books,English Books,
No. of pages:88 Pages
Format:Paperback

This book is printed on demand and is non-refundable after purchase

Available Formats :

Printed Book

It will be sent to your address

SR293
Incl. VAT

Choose your delivery preference

Or

About this Product

Doctoral Thesis / Dissertation from the year 2015 in the subject Medicine - Internal Medicine, grade: passed, University of Basel, course: Pneumologie, language: English, abstract: Background: The prevalence and nature of upper respiratory changes in patients with COPD and its impact on COPD outcomes are unclear. Methods: Patients with stable COPD GOLD stages 1-4 and a control group without COPD matched in gender and age were recruited at the University Hospital Basel. The difference in the Sino-Nasal-Outcome-20 questionnaire (SNOT-20) score was compared between the COPD cohort and the control group. Secondary outcomes were sub-scores SNOT-Primary Nasal Symptoms (SNOT-PNS), SNOT-Secondary Nasal Symptoms (SNOT-SNS) and SNOT-Quality of Life (SNOT-QOL). Abnormal findings were defined as a value of >12 points and absolute values were compared. Furthermore the Rhino-conjunctivitis Quality of Life questionnaire (RQLQ) and three visual analogue scales (VAS) estimating the amount of nasal secretions, bilateral perception of nasal congestion and nasal itching, were applied. As objective clinical surrogate markers for nasal inflammation, computer tomography (CT) scans of the para-nasal sinuses were performed and assessed with the Newman and the Lund-Mackay scoring system. Results: Data from 83 COPD patients (35 females, mean age: 67 years 10) and 34 controls (18 females, mean age: 67 years 12) were analysed. Forty-eight COPD patients (59%) and 14 controls (41%) had an abnormal SNOT-20 score (p=0.088). An abnormal SNOT-PNS score was found in 49 COPD patients (59%) and in 9 controls (26%) (p
Show more

Specifications

SKU9783668100558
Manufacturer Number9783668100558
year published2015
Show more

Report an issue with this product.

Customer Reviews